Integrated Evaluation of Adipokines, Cardiac Biomarkers, and Autonomic Nervous System Activity in Patients with Metabolic Syndrome: A Cross-Sectional Clinical Study
Cross-sectional study shows impaired heart rate variability linked to adipokines in patients with metabolic syndrome, suggesting cardiovascular risk assessment implications.
Key Points
Impaired heart rate variability is significantly associated with altered adipokine levels in metabolic syndrome patients.
Key findings include elevated leptin and resistin levels correlated with abnormal cardiac biomarkers and reduced heart rate variability.
This cross-sectional study evaluated 100 patients diagnosed with metabolic syndrome, assessing various biomarkers and autonomic function.
Integrated evaluation highlights the relationship between adipokine dysregulation and cardiovascular risk, indicating potential future clinical assessments.